Results 141 to 150 of about 393,422 (164)

Chromothripsis is a novel biomarker for prognosis and differentiation diagnosis of pancreatic neuroendocrine neoplasms. [PDF]

MedComm (2020)
Zhang MY, He D, Zhang Y, Cheng K, Li HS, Zhou YW, Long QX, Liu RZ, Liu JY.   +8 more
europepmc   +1 more source

Computed tomography features in prediction of histological differentiation of pancreatic neuroendocrine neoplasms - a single-centre retrospective cohort study. [PDF]

Pol J Radiol
Herzyk JK, Majewska K, Jakimów K, Ciesielka J, Pilch-Kowalczyk J.   +4 more
europepmc   +1 more source

PROTAC-Surufatinib Suppresses Pancreatic Neuroendocrine Neoplasms Progression by Inducing Ferroptosis through Inhibiting WNT/β-catenin Pathway Mediated by HMOX1. [PDF]

Int J Biol Sci
Xue B, Yan L, Ye M, Gu D, Qian J, He N, Hu P, Lu F, Lu X, Liu M, Xu L, Bai J, Wang Y, Zhu G, Tang Q.   +14 more
europepmc   +1 more source

Exploring the therapeutic potential of simvastatin in pancreatic neuroendocrine neoplasms: insights into cell cycle regulation and apoptosis. [PDF]

Transl Cancer Res
Shi XT, Yan LJ, Lu FY, Ye MJ, Yu P, Zhong Y, Chen JH, Hu CH, Tang QY.   +8 more
europepmc   +1 more source

ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin

Modern Pathology, 2013
The human insulin gene enhancer-binding protein islet-1 (ISL1) is a transcription factor involved in the differentiation of the neuroendocrine pancreatic cells.
Giuseppe Zamboni, Abbas Agaimy, Günter Klöppel   +2 more
exaly   +4 more sources

Imaging of Pancreatic Neuroendocrine Neoplasms

International Journal of Environmental Research and Public Health, 2021
Pancreatic neuroendocrine neoplasms (panNENs) represent the second most common pancreatic tumors. They are a heterogeneous group of neoplasms with varying clinical expression and biological behavior, from indolent to aggressive ones.
Diletta Cozzi, Silvia Pradella, Luca Brunese   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database

European Journal of Surgical Oncology, 2022
Guangjun Shi
exaly  

Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009–2018. An in-depth analysis of two population-based cancer registries

Cancer Epidemiology, 2022
Andreas Stang, Bernd Holleczek, Manfred P Lutz   +2 more
exaly  

Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms

Scandinavian Journal of Gastroenterology, 2022
Luhuai Feng, Bixun Li, Tianbao Liao
exaly  

Prognostic value of preoperative diabetes mellitus in patients with non-functional pancreatic neuroendocrine neoplasms

American Journal of Surgery, 2022
Yonghua Chen, Xubao Liu, Chunlu Tan
exaly